Roberts Zachary
- SEC CIK
- 0001851044
In the past year, 2 open-market sale filings worth $104.2K and no purchases.
Current role at each company
- ALLO Allogene Therapeutics, Inc.President and CEOas of Jul 6, 2026
- TIL Instil Bio, Inc.Chief Medical Officeras of Mar 7, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $104.2K
- 2 filings
- Net
- −$104.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Roberts Zachary as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ALLO Allogene Therapeutics, Inc.
President and CEO4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 (view filing) | Feb 2 | 2 days | Roberts ZacharyEVP of R&D | SSale | −35.7K | $1.77 | −$63.2K | −5.8%581.2K after | |
| Jan 23, 2026 (view filing) | Jan 21 | 2 days | Roberts ZacharyEVP of R&D | SSale | −26.3K | $1.56 | −$41.0K | −4.1%616.9K after | |
| Feb 5, 2025 (view filing) | Feb 3 | 2 days | Roberts ZacharyEVP of R&D | SSale | −18.8K | $1.70 | −$32.0K | −2.8%643.1K after | |
| Jan 23, 2025 (view filing) | Jan 21 | 2 days | Roberts ZacharyEVP of R&D | SSale | −27.2K | $1.78 | −$48.4K | −5.3%488.1K after |